Inhibitors of Transcription, Proteasome Inhibitors, and DNA-Damaging Drugs Differentially Affect Feedback of p53 Degradation
- 1 October 1998
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 244 (1) , 54-60
- https://doi.org/10.1006/excr.1998.4193
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Like p53, the Proliferation-Associated Protein p120 Accumulates in Human Cancer Cells Following Exposure to Anticancer DrugsBiochemical and Biophysical Research Communications, 1998
- Loss of function and p53 protein stabilizationOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996
- Induction of apoptosis in HeLa cells by trans-activation-deficient p53.Genes & Development, 1995
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992